Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The anti-inflammatory effect of donepezil on experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.
[Natalizumab and reduction of carbonylated proteins in patients with multiple sclerosis].
Multiple sclerosis.
Health-related quality of life and disease-modifying treatment behaviour in relapsing-remitting multiple sclerosis - a multicentre cohort study.
A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis
Multiple Sclerosis in Children.
Analysis of oxidative stress in zebrafish embryos.
Differential Contributions of Alcohol and Nicotine-Derived Nitrosamine Ketone (NNK) to White Matter Pathology in the Adolescent Rat Brain.
Therapy-related acute leukemia in two patients with multiple sclerosis treated with Mitoxantrone.
Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis.
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies.
Tumefactive MS lesions under fingolimod: A case report and literature review.
In multiple sclerosis oligoclonal bands connect to peripheral B cell responses.
Fingolimod (FTY720) stimulates ca(2+)/calcineurin signaling in fission yeast.
17β-trenbolone, an anabolic-androgenic steroid as well as an environmental hormone, contributes to neurodegeneration.
Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios.
Riluzole enhances glutamate uptake in rat astrocyte cultures.
Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis.
Balance exercise for persons with multiple sclerosis using Wii games: a randomised, controlled multi-centre study.
Fulminant Central Plus Peripheral Nervous System Demyelination without Antibodies to Neurofascin.
Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis.
Subcutaneous interferon β-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective study.
Proceedings of the European Charcot Foundation Symposium A Reappraisal of Nutrition and Environment in Multiple Sclerosis, European Charcot Foundation Symposium, December 2-4, 2010, Fiuggi, Italy.
Stelara (Ustekinumab) receives FDA Approval for Treatment of Moderate to Severe Plaque Psoriasis with Four-Times-A-Year Maintenance Dosing

Pages